ACTRN12612000182897进行中（未招募）4 期
Routine monitoring and evaluation of efficacy and safety of artesunate-mefloquine (ASMQ) in Pailin, and dihydroartemisinin-piperaquine (DP) in Pursat, Kratie, and Preah Vihear for the treatment of uncomplicated Plasmodium falciparum malaria, Cambodia 2011
Global Fund For Malaria0 个研究点目标入组 240 人开始时间: 2012年2月10日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 2 Years 至 o limit（—）
- 性别
- All
入选标准
- •Equal to or greater than 2 years old;
- •-Mono Infection with P. falciparum;
- •-Parasitaemia, 500–200 000 asexual forms per microlitre for P.f;
- •-Axillary temperature greater than 37.5 degree C
- •-Ability to swallow oral medication;
- •-Ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule;
- •-Informed consent from the patient or from a parent or guardian in case of children.
排除标准
- •-Unmarried females aged 12-18 years old
- •-Presence of general danger signs among children <5 years old or other signs of severe and complicated falciparum malaria according to current WHO definitions;
- •-Mixed species;
- •-Presence of febrile conditions due to diseases other than malaria (measles, acute lower tract respiratory infection, severe diarrhea with dehydration, etc.),
- •-Known hypersensitivity or allergy to artesunate or mefloquine
- •-Known psychiatric disorders, e.g. depression or epilepsy
- •-Anti arrhythmic or others drugs which are known to influence cardiac function
研究者
相似试验
已完成
不适用
Routine Monitoring and Evaluation of efficacy and safety of Dihydroartemisinin-Piperaquine in Trapaeng Raeng Centre (Kampot), in Phnom Dek Centre ( Preah Vihear), in Snuol Centre (Kratie), and in Veunsai centre (Ratanakiri) for the treatment of uncompleted Plasmodium falciparum malaria and Plasmodium vivax malaria (Only in Kampot and Ratanakiri) in CambodiaACTRN12614000344695Ministry of Health of Cambodia240
已完成
不适用
Routine Monitoring and Evaluation of efficacy and safety of dihydroartemisinin-piperaquine in Tasagn Health Centre (Battam Bang Province), in Promaoy Health Centre ( Pursat province), in Oral Health Centre (Kampong Speu province), and in Sandan health centre (Kampong Thom province) for the treatment of uncompleted Plasmodium falciparum malaria in Cambodia.ACTRN12615000793516Ministry of Health of Cambodia240
已完成
不适用
Routine Monitoring and Evaluation of efficacy and safety of Dihydroartemisinin-Piperaquine in Kvav Health Centre (Siemreap), in Kbal Romeas ( Stung Treng), in Veurn Sai (Rattanakiri) and in Koh Ngek Health Centre (Mondulkiri) for the treatment of uncomplicated Plasmodium falciparum malaria in Cambodia 2014.ncomplicated Plasmodium falciparum MalariaUncomplicated Plasmodium falciparum MalariaInfection - Other infectious diseasesACTRN12615000696594Ministry of Health, Cambodia120
已完成
不适用
Observational study for evaluation of effecacy and safety of ethinylestradiol therapy for postmenopausal hormone receptor-positive metastatic breast cancer patients heavily pre-treated with endocrine treatmentBreast CancerJPRN-UMIN000010492Study group for metastatic breast cancer65
已完成
不适用
Evaluation of treatment monitoring by quantitative index in bone scintigraphy of patients with bone metastasisPatients with bone metastasisJPRN-UMIN000026971Gifu University Graduate School of Medicine200